GlassScriptPhysician profile
Robert D Wardlow
NPI 1215359955
$2,607.81
in general payments reported to CMS, 2019-2025
11 companies · $2,539 in 2025
The $2,539 reported for 2025 was more than what 92% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $68.75 · 2025: $2,539.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,447 · Food and Beverage: $1,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,446.55 |
| Food and Beverage | $1,092.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,043.37 | 2025 | Inspire |
| Optinose US, INC. | $157.26 | 2025 | |
| Stryker Corporation | $106.03 | 2022-2025 | Scopis Ent |
| Depuy Synthes Sales INC. | $83.11 | 2025 | Matrixmidface, Matrixmandible, Na |
| Glaxosmithkline, LLC. | $42.65 | 2025 | Nucala |
| Ars Pharmaceuticals Operations, INC. | $35.26 | 2025 | Neffy |
| Biocryst US Sales Co., LLC | $34.83 | 2025 | Orladeyo |
| Genentech USA, INC. | $32.46 | 2025 | Xolair |
| Incyte Corporation | $29.42 | 2025 | Opzelura |
| Aerin Medical INC. | $24.32 | 2025 | |
| Greer Laboratories, INC. | $19.10 | 2025 | Oralair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wardlow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.